Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Implementation of DPYD and UGT1A1 Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical Trial.
Journal: JCO precision oncology
Published: August 07, 2025
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing.
Journal: Frontiers in oncology
Published: January 21, 2022
Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.
Journal: BMC cancer
Published: June 01, 2021
DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation.
Journal: Pharmacotherapy
Published: September 28, 2020
The effects of lapatinib on CYP3A metabolism of midazolam in patients with advanced cancer.
Journal: Cancer chemotherapy and pharmacology
Published: September 14, 2017
Pro Re Nata (PRN) prescription in an Inpatient Low Secure Learning Disability Unit.
Journal: Psychiatria Danubina
Published: September 30, 2015
Showing 1-6 of 6
Last Updated: 09/26/2026